Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 1,804 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arthritis, Degenerative Clear all

Conditions: Osteoarthritis (OA) of the Knee
Interventions: TPX-100 200mg, Once weekly for 4 weeks, PBS; Drug · Other
Lead sponsor: OrthoTrophix, Inc; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 33
States / cities: Scottsdale, Arizona • Tucson, Arizona • Carrolton, California + 26 more

Conditions: Hip Osteoarthritis, Knee Osteoarthritis
Interventions: Educational intervention; Other
Lead sponsor: West Virginia University; Other
Eligibility: 45 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Osteoarthritis
Interventions: Meloxicam Test Capsules, Placebo Capsules; Drug
Lead sponsor: Iroko Pharmaceuticals, LLC; Industry
Eligibility: 40 Years and older
Enrollment: 403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 40
States / cities: Birmingham, Alabama • Carmichael, California • Pismo Beach, California + 31 more

Conditions: Osteoarthritis, Knee, Hypertension
Interventions: STAR Intervention, Attention-Control; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 50 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Knee Osteoarthritis
Interventions: PRP Treatment, HA Treatment; Biological
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Osteoarthritis, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis (OA) of the Hip
Interventions: Prednisone, Dexamethasone, Placebo; Drug
Lead sponsor: WellSpan Health; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: York, Pennsylvania

Conditions: Total Shoulder Arthroplasty
Interventions: Subscapularis-Sparing Total Shoulder Arthroplasty; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Osteoarthritis
Interventions: Myalgesin™ (celery seed extract, Boswellia serrata extract, Phellodendron extract); Dietary Supplement
Lead sponsor: ProThera, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Albany, New York

Conditions: Osteoarthritis of the Knee
Interventions: Lorecivivint; Drug
Lead sponsor: Biosplice Therapeutics, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 4
States / cities: Tucson, Arizona • Winter Park, Florida • Oak Brook, Illinois + 1 more

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Risk Status Optimization; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Joint Disease
Interventions: Total Knee Arthroplasty (EVOLUTION®); Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Morton Grove, Illinois

Conditions: Osteoarthritis, Arthroplasty
Interventions: Ropivacaine with NaCl, Epinephrine, Morphine, Ketorolac Tromethamine, Ropivacaine; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Osteoarthritis
Interventions: Fit and Strong!; Behavioral
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 60 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1983 – 2003
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Thumb Osteoarthritis
Interventions: Denervation of the thumb CMC joint, trapeziectomy with ligament reconstruction (LRTI); Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis
Interventions: Tetracycline, Demeclocycline, Total Hip Replacement; Other · Procedure
Lead sponsor: Amgen; Industry
Eligibility: 50 Years to 100 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: West Haverstraw, New York

Conditions: Degenerative Joint Disease of Shoulder
Interventions: Cryoneurolysis, No cryoneurolysis; Device · Other
Lead sponsor: North Texas Medical Research Institute, PLLC; Other
Eligibility: 30 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rockwall, Texas

Conditions: Osteoarthritis
Interventions: Decision Aid Video, Motivational Interviewing, MI plus Decision aid, Attention control; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 663 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 3
States / cities: Cleveland, Ohio • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Osteoarthritis of Facet Joint of Lumbar Spine
Interventions: Adipose-derived stem cell injection, Corticosteroid injection; Device · Drug
Lead sponsor: InGeneron, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 2
States / cities: Deerfield Beach, Florida • Sioux Falls, South Dakota

Conditions: Hip Osteoarthritis, Hip Arthritis
Interventions: Alexis wound retractor, Standard wound retractor; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Knee Osteoarthritis
Interventions: Orthopaedic manual physical therapy, Corticosteroid Injection; Procedure
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 38 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 2
States / cities: San Antonio, Texas • Tacoma, Washington

Conditions: Osteoarthritis, Osteo Arthritis Knee
Interventions: OA-SYS; Drug
Lead sponsor: Ageless Biotech, Inc.; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Osteoarthritis, Knee
Interventions: PF-04191834, PF-04191834 placebo, Naproxen placebo, Naproxen; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 25
States / cities: Peoria, Arizona • Phoenix, Arizona • Anaheim, California + 20 more

Conditions: Osteoarthritis, Knee
Interventions: Ibuprofen, celecoxib, placebo; Drug · Other
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 33
States / cities: Anniston, Alabama • Phoenix, Arizona • Anaheim, California + 30 more

Conditions: Osteoarthritis
Interventions: Ankle distraction permitting motion, Ankle distraction without motion; Procedure
Lead sponsor: Ned Amendola; Other
Eligibility: Up to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Leisure Expectations About Physical Activity Study

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension

Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis

Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department

Subscapularis-Sparing Total Shoulder Arthroplasty

Efficacy of Myalgesin™ to Support Joint Function in Patients With Knee Osteoarthritis

3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis

Hip and Knee Scoring System to Predict Complication Rate and Candidacy for Total Hip and Knee Arthroplasty

Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts

Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty

Impact of Exercise on Older Persons With Osteoarthritis

Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

Educational Intervention for Knee Pain

Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint

Alexis Retractor in Total Hip Arthroplasty

A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis

An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)

Prevention of Post-Traumatic Osteoarthritis (OA)